MedTrace Logo

A Registration Study to Evaluate the Performance of CHIRON® RIBA® HCV 3.0 SIA in HCV Antibody Detection

NCT01582594 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 795

Last updated 2013-06-28

No results posted yet for this study

Summary

To evaluate the accuracy of the CHIRON® RIBA® HCV 3.0 (RIBA, Investigational Product) test using known anti-HCV seropositive and seronegative specimens.

Registration for license application

Conditions

  • Hepatitis C

Sponsors & Collaborators

  • Johnson & Johnson Medical, China

    lead INDUSTRY

Principal Investigators

  • Yuanli Mao, Professor · Beijing 302 Hospital

  • Yanping Luo, Professor · Chinese PLA General Hospital

  • Xinxin Zhang, Professor · Ruijin Hospital

  • Tai Guo, Director · National Institites of Food and Drug control

Eligibility

Min Age
1 Year
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2012-08-31
Completion
2013-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01582594 on ClinicalTrials.gov